(Q34459382)

2 August 2017

1 reference

title

RNA-based gene therapy for HIV infection (English)

1 reference

2 August 2017

0 references

Dorman N

1

1 reference

2 August 2017

Lever AM

series ordinal

2

1 reference

2 August 2017

publication date

1 April 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

2

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

114-122

1 reference

Mechanism of action of antisense RNA. Sometime inhibition of transcription, processing, transport, or translation

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

What makes an mRNA anti-sense-itive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Properties of cloned and expressed human RNase H1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Inhibition of HIV-1 multiplication in a human CD4+ lymphocytic cell line expressing antisense and sense RNA molecules containing HIV-1 packaging signal and Rev response element(s)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

A good antisense molecule is hard to find

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Ribozyme targeting of HIV-1 LTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Inhibition of human immunodeficiency virus type 1 replication by nuclear chimeric anti-HIV ribozymes in a human T lymphoblastoid cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Preclinical characterization of an anti-tat ribozyme for therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Artificial capillary culture: expansion and retroviral transduction of CD4+ T-lymphocytes for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Phosphorothioate antisense oligodeoxynucleotides: questions of specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

DNA aptamers selected against the HIV-1 trans-activation-responsive RNA element form RNA-DNA kissing complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Expression of naturally occurring antisense RNA inhibits human immunodeficiency virus type 1 heterologous strain replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Inhibition of transcription by the TAR RNA of HIV-1 in a nuclear extract of HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Expression of the human immunodeficiency virus type 1 primer binding sequence inhibits HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Inhibition of human immunodeficiency virus expression by sense transcripts encoding the retroviral leader RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Specific inhibition of human immunodeficiency virus type 1 replication by RNA transcribed in sense and antisense orientation from the 5'-leader/gag region

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Efficacy of antitat gene therapy in the presence of high multiplicity infection and inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Expression of small, therapeutic RNAs in human cell nuclei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2001.00052.X

10.1046/J.1468-1293.2001.00052.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference